Medopad
Allows doctors to access and analyse patients' data
Total raised
€51M
€50,506,363
Funding rounds
5
Investors
3
distinct backers
Active since
2011-12
latest 2019-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood18
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 5 rounds raised
- ▲ €30M+ raised
- ▲ 15y since founding
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B | €23M | Bayer | View deal → |
| 2018-01-01 | Other | €25M | NWS Holdings | View deal → |
| 2014-03-01 | Seed | €636k | Vodafone | View deal → |
| 2013-06-01 | Other | €900k | — | View deal → |
| 2012-01-01 | Other | €990k | — | View deal → |